|
Docu-menta >
Buscar por Autor Quintana-Bustamante, O
Mostrando resultados 14 a 17 de 17
Fecha de publicación | Título | Autor(es) | jul-2021 | Preclinical studies of efficacy thresholds and tolerability of a clinically ready lentiviral vector for pyruvate kinase deficiency treatment | Navarro, S; Quintana-Bustamante, O; Sanchez-Dominguez, R; Lopez-Manzaneda, S; Ojeda-Perez, I; Garcia-Torralba, A; Alberquilla, O; Law, K; Beard, BC; Bastone, A; Rothe, M; Villanueva, M; Ramirez, JC; Fañanas-Baquero, S; Nieto-Romero, V; Gutierrez, S; Nicoletti, E; García-Bravo, M; Bueren, JA; Schwartz, JD; Segovia, JC |
mar-2016 | Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα | Bueno, C; Sardina, JL; Di Stefano, B; Romero-Moya, D; Muñoz-López, A; Ariza, L; Chillón, MC; Balanzategui, A; Castaño, J; Herreros, A; Fraga, MF; Fernández, A; Granada, I; Quintana-Bustamante, O; Segovia, JC; Nishimura, K; Ohtaka, M; Nakanishi, M; Graf, T; Menedez, P |
dic-2009 | Rescue of Pyruvate Kinase Deficiency in Mice by Gene Therapy Using the Human Isoenzyme | Meza, NW; Alonso-Ferrero, ME; Navarro, S; Quintana-Bustamante, O; Valeri, A; Garcia-Gomez, M; Bueren, JA; Bautista, JM; Segovia, JC |
6-abr-2014 | Targeted gene therapy and cell reprogramming in Fanconi anemia | Rio, P; Baños, R; Lombardo, A; Quintana-Bustamante, O; Alvarez, L; Garate, Z; Genovese, P; Almarza, E; Valeri, A; Díez, B; Navarro, S; Torres, Y; Trujillo, JP; Murillas, R; Segovia, JC; Samper, E; Surralles, J; Gregory, PD; Holmes, MC; Naldini, L; Bueren, JA |
Mostrando resultados 14 a 17 de 17
|